Ramiro Gilardino

Peer Reviewed Publications

30+ peer-reviewed publications across health economics, HTA reform, and global health policy

No publications found.

Peer Reviewed Publications

Peer Reviewed Publications

  1. Cossio, M. C., & Gilardino, R. (2026). Beyond efficiency: reimagining health technology assessment in the age of artificial intelligence. International Journal of Technology Assessment in Health Care, 42(1), e44. Link
  2. Cossio, M., & Gilardino, R. E. (2025). Bridging the patient gap: exploring generative AI to support meaningful patient involvement in health technology assessment. Journal of Comparative Effectiveness Research, 14(12), e250150. Link
  3. Gilardino, R., Mittmann, N., Mueller, D., & Pichler, F. (2025). Reframing early health technology assessment through a lifecycle lens: Commentary on “defining early health technology assessment: building consensus using Delphi technique”. International Journal of Technology Assessment in Health Care, 42(1), e38. Link
  4. Coombes, M. A., Morgan, K., Diaz, J., Oehrlein, E. M., Andersen, H., Gilardino, R., Helme, K., Pearce, F., & Cardone, A. (2025). Plain language summaries supporting patient involvement: lessons and guidance from HTAi Patient and Citizen Involvement Interest Group (PCIG). International Journal of Technology Assessment in Health Care, 41(1), e59. Link
  5. Fernández, R. O., Alvarez, F., & Gilardino, R. (2025). “Geriatric patients in Argentinean ICUs: admission, care patterns, outcomes and healthcare system implications”. BMC Geriatrics, 25(1), 506. Link
  6. Kumar, G., Radu, P., Cubi-Molla, P., Garau, M., Bell, E., Pan, J., Gilardino, R., Van Bavel, J., Brandtmüller, A., Nelson, K., & Goodall, M. (2025). Navigating change: A comparative analysis of health technology assessment reforms across agencies – Processes, drivers, and interdependencies. International Journal of Technology Assessment in Health Care, 41(1), e21. Link
  7. Pannelay, A. J., Gilardino, R. E., & Ramagopalan, S. V. (2025). Access in all areas? A roundup of developments in market access and health technology assessment: Part 6. Journal of Comparative Effectiveness Research, 14(3), e240239. Link
  8. Pichler, F. B., Boysen, M., Mittmann, N., Gilardino, R., Bruce, A., Bond, K., & Vreman, R. A., et al. (2024). An operationalization framework for lifecycle HTA. International Journal of Technology Assessment in Health Care, 1–29. Link
  9. Pichler, F. B., Boysen, M., Mittmann, N., Gilardino, R., Bruce, A., Bond, K., & Vreman, R. A., et al. (2024). Lifecycle HTA: Promising applications and a framework for implementation: An HTAi Global Policy Forum Task Force Report. International Journal of Technology Assessment in Health Care, 1–25. Link
  10. Gilardino, R., Treharne, C., Mardiguian, S., & Ramagopalan, S. V. (2023). Access in all areas? A roundup of developments in market access and health technology assessment: Part 1. Journal of Comparative Effectiveness Research. Link
  11. Gilardino, R., Gallesio, A., Arias-López, M. P., Boada, N., Mandich, V., Sagardia, J., Ratto, M. E., & Fernández, A. (2022). Current stage of the intensive care unit structure in Argentina: Results from the Sociedad Argentina de Terapia Intensiva self-assessment survey of intensive care units. Revista Brasileira de Terapia Intensiva, 34(2), 237-246. Link
  12. Gilardino, R. E., Valanzasca, P., & Rifkin, S. B. (2022). Has Latin America achieved universal health coverage yet? Lessons from four countries. Archives of Public Health, 80, 38. Link
  13. Malek Pascha, V. A., Sun, L., Gilardino, R., & Legood, R. (2021). Telemammography for breast cancer screening: A cost-effective approach in Argentina. BMJ Health Care Informatics, 28(1), e100351. Link
  14. Guarin, D., Monsanto, H., Gilardino, R., et al. (2021). Value assessment frameworks in Latin America: “Il buono, il brutto e il cattivo”. Value in Health Regional Issues, 26, 50–55. Link
  15. Cossio, C. M., & Gilardino, R. E. (2021). Would the use of artificial intelligence in COVID-19 patient management add value to the healthcare system? Frontiers in Medicine. Link
  16. Gilardino, R. E. (2020). Does “flattening the curve” affect critical care services delivery for COVID-19? A global health perspective. International Journal of Health Policy and Management. Link
  17. Arias-López, M. D. P., Mandich, V., Mosciaro, M., Ratto, M. E., Chaparro Fresco, J., Boada, N., & Gilardino, R. (2020). [Recommendations for resource management in intensive care units during the COVID-19 pandemic]. Medicina, 80(Suppl 3), 67–76.
  18. Gilardino, R., Mejía, A., Guarin, D., Rey-Ares, L., & Perez-Galan, A. (2019). Implementing HTA in Latin America: Looking at the past, mirroring the future. Value in Health Regional Issues, 23(c), 6–12. Link
  19. Mejía, A., Gilardino, R., Kristensen, F. B., & Garrison, L. P. (2018). Value-based pricing in Latin America: How far away are we? Value in Health Regional Issues, 17, 219–223. Link
  20. Gilardino, R. E., Gonzalez-Pier, E., & Brabata, C. (2018). End-stage renal disease models in the Americas: Optimizing resources to achieve better health outcomes. Value in Health Regional Issues, 17, 115–118. Link
  21. Rey-Ares, L., Hernández-Vásquez, A., Garay, O. U., Pichon-Riviere, A., Garcia Marti, S., Gilardino, R., et al. (2016). Medical devices: From licensing to coverage. Highlights from Argentina, Brazil, Colombia, and Mexico. Expert Review of Medical Devices, 13(11).

Conference Papers & Abstracts

  1. Capdevila, C., Pistollato, M., Krueger, T., Roediger, A., & Gilardino, R. (2023). HPR94 Treating Early Often Comes Too Late: Ensuring Patient Access to Early Cancer Detection and Treatment in Europe. Value in Health, 26(12), S270. Link
  2. Bell, E., Cubi-Molla, P., Garau, M., Kumar, G., Pan, J., Radu, P., Baxter, C., Gilardino, R., Goodall, M., Nelson, K., et al. (2023). P46 Drivers of Health Technology Assessment Methods and Process Reforms: An International Comparison of Real World Evidence, Patient Involvement and Discounting. Value in Health, 26(12), S11-S12.
  3. Cossio, M., & Gilardino, R. (2023). CO146 Language Model-Based Approach for Extracting Comorbidities and Complications in Fabry Disease Clinical Notes. Value in Health, 26(12), S41.
  4. Breslau, R., Neumann, P., Cohen, J., Diaz, J., Huetson, P., & Gilardino, R. (2023). P18 A Review of HTA Guidelines on Societal and Novel Value Elements. Value in Health, 26(6), S4-S5.
  5. Cossio, M., & Gilardino, R. (2023). HSD81 Automated Report Generation with Chat GPT API for Cardiology: Performance Evaluation and Impact on Physician Burnout. Value in Health, 26(12), S309.
  6. Cossio, M., & Gilardino, R. (2023). RWD182 Influence of Multiple Instance Learning on the Generation of Computational Pathology Algorithms and Its Value-Based Impact. Value in Health, 26(6), S396.
  7. Cossio, C. M., & Gilardino, R. E. (2023). Multidimensional Analysis of the Implementation and Impact of Digital Twins in Healthcare. Value in Health, 26(6), S388-389.
  8. Cossio, M., & Gilardino, R. (2022). Electronic Health Records With Unstructured Text to Predict Outcomes With Machine Learning: A Therapeutic Area Fingerprint. ISPOR Europe 2022, Vienna, Austria.
  9. Cossio, C. M., & Gilardino, R. (2022). The Use of Machine Learning in Electronic Health Records Disease Analysis: An Updated Perspective. Value in Health, 25(7), S576-S577.
  10. Rizzo, E., Malek Pascha, V., Gilardino, R., & Belk, K. (2022). Racial Disparities in Colorectal Cancer Outcomes: How Community Health Workers Can Increase Screening Uptake in the US. Value in Health, 25(7), S435.
  11. Costa, L., Hincapie, A. L., Gilardino, R., Tang, B., Julian, G., Soares, C. S., et al. (2021). PNS118 Real World Evidence (RWE) Use in Latin America Healthcare Decision Making: An Stakeholder Survey Analysis. Value in Health, 24, S194R.
  12. Gilardino, R., Guarin, D., Bustos Márquez, M. C., & Forero, J. C. (2021). PMU43 VALUE-Based Pricing in Colombia: The Devil Is in the Details. Value in Health, 24(Suppl 1), S152. Link
  13. Gilardino, R., Gallesio, A., Arias Lopez, M. P., Boada, N., Sagardia, J., Mandich, V., Chaparro, J., Cosenza, S., Fernández, A., & Ratto, M. E. (2020). Recursos físicos y tecnológicos de las unidades de cuidados intensivos en Argentina: Análisis de encuesta de autocategorización. 30° Congreso Virtual Argentino-Internacional de Terapia Intensiva, Buenos Aires.
  14. Alfonso-Cristancho, R., Brabata, C., Gilardino, R., Guarín, D. F., Monsanto, H., Díaz Toro, Y. R., González, L., et al. (2019). Defining “value” in Latin America: The good, the bad and the ugly. Value in Health Regional Issues. Link
  15. Hincapié, A., Machnicki, G., Julian, G., Gilardino, R., Soares, C. S., Costa, L., Tang, B., & Rojas, R. (2019). Real-world evidence landscape in Latin America healthcare decision making: Exploring understanding, acceptability and use. Value in Health Regional Issues. Link
  16. Gilardino, R. E., Koffmon, A. A., & Cabra, H. A. (2015). Access to imported medical devices due to inflation and underfunding of Argentinean Health Sector in 2013. Value in Health, 18(3), A-50.
  17. Rey-Ares, L., Garay, U., Garcia-Marti, S., Gilardino, R., Cabra, H., Pichon-Riviere, A., & Augtovski, F. (2015). Medical Devices – From Licensing to Coverage: Highlights from Argentina, Brazil, Colombia and Mexico. Value in Health, 18(3), A-807.
  18. Roy, S., Schiff, A., Cabra, H. A., Andrade, P. C., Zanela, O. O., Junqueira, S., Ghosh, S. K., & Gilardino, R. (2015). The economic value proposition of hand-sewn suture versus stapled anastomoses during right colon surgery. Value in Health, 18(3), A-817.
  19. Gilardino, R., Cabra, H., Acosta, J., Wallace, D., & Lopez, M. (2015). Análisis del impacto económico de la adopción de una técnica mínimamente invasiva para la reparación de hernia ventral: Perspectiva de 4 países de América Latina. Value in Health, 18(3), A-852.
Conference Papers and Abstracts

 

Download full publications list (PDF)